# Coya Therapeutics, Inc.: Form DEF 14A, filed Mar 28, 2024

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: DEF 14A
- Filed: 2024-03-28
- Accepted by EDGAR: Mar 28, 2024, 20:30 ET
- Period: 2024-05-08
- Accession: 0000950170-24-038090
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000095017024038090/coya_proxy_2023.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000095017024038090/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000095017024038090/coya_proxy_2023.htm

Filed Mar 28, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-038090. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.